loading
前日終値:
$11.63
開ける:
$11.63
24時間の取引高:
77,190
Relative Volume:
0.59
時価総額:
$96.98M
収益:
当期純損益:
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$0.00
$0.00
1週間の範囲:
Value
$10.16
$12.50
52週間の値動き範囲:
Value
$10.16
$12.50

Retension Pharmaceuticals, Inc. Common Stock Stock (RTSN) Company Profile

Name
名前
Retension Pharmaceuticals, Inc. Common Stock
Name
セクター
Healthcare (1051)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
null
Name
最新のSEC提出書
Name
RTSN's Discussions on Twitter

Compare RTSN vs VRTX, MRNA, REGN, ARGX, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
RTSN icon
RTSN
Retension Pharmaceuticals, Inc. Common Stock
11.64 96.98M 0 0 0 0.00
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
498.50 126.35B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
226.30 90.35B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
778.36 80.14B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
818.30 51.46B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
193.52 41.48B 742.00K -1.37B -1.07B -7.0731

Retension Pharmaceuticals, Inc. Common Stock (RTSN) 最新ニュース

pulisher
Oct 13, 2026

With 402,577 common shares, Retension Pharmaceuticals (RTSN) CEO also holds options priced from $1.43. - Stock Titan

Oct 13, 2026
pulisher
Oct 13, 2026

CEO buys 20,800 shares and receives 255,174 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan

Oct 13, 2026
pulisher
Oct 13, 2026

A director buys at $12 a share and converts preferred stock at Retension Pharmaceuticals (RTSN). - Stock Titan

Oct 13, 2026
pulisher
Oct 13, 2026

Director Pavan Cheruvu receives 5,636 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan

Oct 13, 2026
pulisher
Oct 12, 2026

Total common shares outstanding of RETENSION PHARMACEUTICALS INC – NASDAQ:RTSN - TradingView

Oct 12, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest press releases and corporate news - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) valuation measures and financial statistics - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) analyst ratings, estimates and forecasts - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) cash flow - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock historical prices and data - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) company profile and facts - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) options chain - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 09, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 09, 2026
pulisher
Oct 09, 2026

RTSN Interactive Stock Chart | Retension Pharmaceuticals, Inc. Common Stock Stock - Yahoo Finance

Oct 09, 2026
pulisher
Oct 09, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Ratings, Estimates & ForecastsYahoo Finance - Yahoo! Finance Canada

Oct 09, 2026
pulisher
Oct 09, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest stock news and headlines - Yahoo Finance UK

Oct 09, 2026
pulisher
Oct 09, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) interactive stock chart - Yahoo Finance UK

Oct 09, 2026
pulisher
Oct 08, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock major holders - Yahoo Finance UK

Oct 08, 2026
pulisher
Oct 08, 2026

Retension Pharmaceuticals Announces Pricing of Initial Public Offering - Yahoo! Finance Canada

Oct 08, 2026
pulisher
Oct 08, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock price, news, quote and history - Yahoo Finance UK

Oct 08, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) 財務データ

Retension Pharmaceuticals, Inc. Common Stock (RTSN) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Retension Pharmaceuticals, Inc. Common Stock (RTSN) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
BERGER FRANKLIN M
Director
Oct 13 '26
Buy
12.00
10,000
120,000
10,000
$5.465
price down icon 6.10%
$18.00
price down icon 0.83%
$10.29
price down icon 0.19%
$6.80
price down icon 3.13%
$7.40
price up icon 5.71%
$10.23
price down icon 1.54%
大文字化:     |  ボリューム (24 時間):